Depression Researcher Dr. Maurizio Fava Joins PharmaTher as Scientific and Clinical Advisor Mar 17 • 4 min read Newscope Capital Corporation, through its wholly-owned subsidiary, PharmaTher Inc., announced the appointment of Dr. Maurizio Fava, MD, as a scientific and clinical advisor for PharmaTher’s clinical research initiatives with KETABET™
Red Light Holland Completes Sale of iMicrodose Psychedelic Truffles into Canada Mar 16 • 5 min read Red Light Holland Corp. announced it has completed the sale and import of the Company’s high-grade consumer packaged goods from the Netherlands to Canada under a Health Canada psilocybin import permit.
Numinus Wellness Inc. Announces $30 Million Bought Deal Public Offering Mar 15 • 4 min read Numinus Wellness Inc. announced that it has entered into an agreement with Eight Capital and Canaccord Genuity Corp.
Family of Bob Marley and Silo Wellness Collaborate to Debut Psychedelic Mushroom Brand Mar 12 • 5 min read Silo Wellness Inc. announced it has entered into a multi-year license agreement with the family of legendary musician Bob Marley for the exclusive worldwide rights to brand, market and sell a distinct product line of functional and psychedelic mushrooms.
NeonMind Engages Certara to Advance Synthetic Psilocybin Drug Candidates for Obesity Mar 11 • 4 min read NeonMind Biosciences Inc. announced that on March 10, 2021 NeonMind engaged Certara® to provide strategic integrated drug development support for the investigation of NeonMind’s psilocybin-based drug candidates for the treatment of obesity.